These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22342653)

  • 1. Accuracy, risk and the intrinsic value of diagnostic imaging: a review of the cost-utility literature.
    Otero HJ; Fang CH; Sekar M; Ward RJ; Neumann PJ
    Acad Radiol; 2012 May; 19(5):599-606. PubMed ID: 22342653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth and quality of the cost-utility literature, 1976-2001.
    Neumann PJ; Greenberg D; Olchanski NV; Stone PW; Rosen AB
    Value Health; 2005; 8(1):3-9. PubMed ID: 15841889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis in the assessment of diagnostic imaging technologies.
    Gazelle GS; McMahon PM; Siebert U; Beinfeld MT
    Radiology; 2005 May; 235(2):361-70. PubMed ID: 15858079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility analyses of diagnostic laboratory tests: a systematic review.
    Fang C; Otero HJ; Greenberg D; Neumann PJ
    Value Health; 2011 Dec; 14(8):1010-8. PubMed ID: 22152169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adoption of cost-effectiveness acceptability curves in cost-utility analyses.
    Meckley LM; Greenberg D; Cohen JT; Neumann PJ
    Med Decis Making; 2010; 30(3):314-9. PubMed ID: 19773582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical value vs cost and risk: redux.
    Thrall JH
    J Am Coll Radiol; 2010; 7(2):81-2. PubMed ID: 20142076
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effective diagnostic cardiovascular imaging: when does it provide good value for the money?
    Otero HJ; Rybicki FJ; Greenberg D; Mitsouras D; Mendoza JA; Neumann PJ
    Int J Cardiovasc Imaging; 2010 Aug; 26(6):605-12. PubMed ID: 20446040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing face of the cost-utility literature, 1990-2012.
    Neumann PJ; Thorat T; Shi J; Saret CJ; Cohen JT
    Value Health; 2015 Mar; 18(2):271-7. PubMed ID: 25773562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technology assessment: scientific challenges.
    Royal HD
    AJR Am J Roentgenol; 1994 Sep; 163(3):503-7. PubMed ID: 8079834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare's national coverage determinations in diagnostic radiology: examining evidence and setting limits.
    Otero HJ; Chambers JD; Bresnahan BW; Kamae MS; Yucel KE; Neumann PJ
    Acad Radiol; 2012 Sep; 19(9):1060-5. PubMed ID: 22748382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty years of cost-effectiveness analysis in medical imaging: are we improving?
    Otero HJ; Rybicki FJ; Greenberg D; Neumann PJ
    Radiology; 2008 Dec; 249(3):917-25. PubMed ID: 19011188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for preclinical disease: test and disease characteristics.
    Herman CR; Gill HK; Eng J; Fajardo LL
    AJR Am J Roentgenol; 2002 Oct; 179(4):825-31. PubMed ID: 12239019
    [No Abstract]   [Full Text] [Related]  

  • 14. Measuring costs in cost-utility analyses. Variations in the literature.
    Stone PW; Chapman RH; Sandberg EA; Liljas B; Neumann PJ
    Int J Technol Assess Health Care; 2000; 16(1):111-24. PubMed ID: 10815358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Approach in Fetal Coarctation of the Aorta: A Cost-Utility Analysis.
    Evers PD; Ranade D; Lewin M; Arya B
    J Am Soc Echocardiogr; 2017 Jun; 30(6):589-594. PubMed ID: 28410945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 30 years of pharmaceutical cost-utility analyses: growth, diversity and methodological improvement.
    Neumann PJ; Fang CH; Cohen JT
    Pharmacoeconomics; 2009; 27(10):861-72. PubMed ID: 19803540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease.
    Zhou T; Chen Z; Li H; Xie F
    Med Decis Making; 2021 Aug; 41(6):685-692. PubMed ID: 33813938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provider cost transparency alone has no impact on inpatient imaging utilization.
    Durand DJ; Feldman LS; Lewin JS; Brotman DJ
    J Am Coll Radiol; 2013 Feb; 10(2):108-13. PubMed ID: 23273974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family Spillover Effects in Pediatric Cost-Utility Analyses.
    Lavelle TA; D'Cruz BN; Mohit B; Ungar WJ; Prosser LA; Tsiplova K; Vera-Llonch M; Lin PJ
    Appl Health Econ Health Policy; 2019 Apr; 17(2):163-174. PubMed ID: 30350218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to report a research study.
    Cronin P; Rawson JV; Heilbrun ME; Lee JM; Kelly AM; Sanelli PC; Bresnahan BW; Paladin AM
    Acad Radiol; 2014 Sep; 21(9):1088-116. PubMed ID: 25107863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.